Navigation Links
A Breath of Fresh Air From Washington: Senate Passes Historic Asbestos Ban
Date:10/10/2007

WASHINGTON, Oct. 10 /PRNewswire-USNewswire/ -- Asbestos in the U.S. may be breathing its last gasps, with the Senate's recent passage of the Ban Asbestos in America Act this past week. It now moves on to the House of Representatives, where passage is expected to be imminent. Championed by Senator Patty Murray (D-WA) for the last six years, this legislation would prohibit the sale of asbestos, launch a public education campaign and invest federal funding in developing effective treatment for Mesothelioma (Meso) and other asbestos-related diseases. With bipartisan support provided by Senator Johnny Isakson (R-GA), the bill was first approved unanimously on August 2nd 2007 in the Senate Committee on Environment and Public Works, chaired by Senator Barbara Boxer (D-CA), and passed by the full Senate on Thursday, October 4th.

Not coincidentally, The International Symposium on Malignant Mesothelioma, led by the Mesothelioma Applied Research Foundation (Meso Foundation), took place this past week in Washington, D.C. During the three-day symposium, 120 Meso Foundation advocates from 26 states converged on the Capitol. They met with their senators and congressional representatives to raise awareness about the tragic toll of Meso, to advocate for research investment and to call for passage of the ban legislation. The Symposium also included scientific presentations from expert researchers and clinicians, information and support for Meso patients and family members, and further advocacy to help secure ultimate passage of the bill.

In comments to the group immediately following the legislation's passage in the Senate, Senator Patty Murray (D-WA) thanked Johnny Isakson (R-GA) and Barbara Boxer (D-CA) for their support of the bill, and credited the Meso Foundation advocates for their role in the passage of the legislation.

"I'm very pleased that Senators from both sides of the aisle came together to unanimously support my bill. This is a historic day in t
'/>"/>

SOURCE Mesothelioma Applied Research Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Individuals with sleep related breathing disorders more prone to heart disease
3. A unique factor in breathing disorder
4. Germs to blame for bad breath
5. Breathing Cancer Causing Compounds During Pregnancy Found To Affect Offspring
6. Sugar-Free Yogurt Can Stop Bad Breath
7. Brain damage can affect children who stop breathing
8. Another Breather For People At Atherosclerotic Risk
9. Shortness Of Breath A More Reliable Indicator Of High Risk Cardiac Disease
10. Shortness Of Breath An Important Indicator Of Heart Attack
11. A breather for nuts in health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3
...s remains one of the significant health problems t...ment. It requires a multi faceted approach. A prot...in Type II diabetes. A recent study shows that con...o acid mixture with carbohydrates increases insuli...
...e those days when drinking was considered to be fo...or a socialite. A new research has found that dri...safe limits have been reported to have better verb...g than those at the extremes of the drinking spect...
...s now emerging as the choice by many for latest an...lying her fourteen-year-old son, Elliot Knott to I... to wait months for an operation in the NHS. The...has been taken after being informed that the patie...
...hursday announced a grant of $7 million for upgrad...istance would enable the Sardar Vallavbhai Patel P...to improve its medical facilities and effectively ...on of healthcare to a wider population," said a st...
Other Medicine News:Health News:Increasing Insulin Response In Type 2 Diabetics With New Protein Mixture 2Health News:Yet Another Reason To Celebrate Drinking 2Health News:Indian Hospitals – A Destination For Quality Medical Care 2
(Date:5/21/2008)... HILDEN, Germany, May 21 /...V Test as Front-line,Screen, Long-term data from ...Cancer show that women screened only with a human ...o develop moderate to severe cervical disease over...onal cytology (the Pap,"smear"). The research foll...
(Date:5/20/2008)...Statistically Significant Reduction of IBS Pain an...Effect Observed, SAN DIEGO, May 20 /...results of a recent Phase 2b study of its oral kap...onstrated statistically significant,results in the...adoline,produced significant improvement in diarrh...
(Date:5/20/2008)... 94 Percent of Men Maintained Normal Testosteron...Treatment 92 Percent of Men Expressed Sat...- Indevus,Pharmaceuticals, ... NEBIDO(R),(testosterone undecanoate), an investig...he treatment of hypogonadism, was presented in a l...
(Date:5/20/2008)...ata on Newly-Approved Cimzia(R) Presented at Diges...swire/ -- UCB announced today that data,presented ...sustainable,efficacy and safety of Cimzia(R) (cert...ts with moderate to severe Crohn,s disease. Data a...y of responders and the remission,rate remained st...
Breaking Medicine Technology:Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 2Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 4Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 2Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 3Tioga Pharmaceuticals' Asimadoline Demonstrates Positive Results in a Phase 2b Clinical Trial for the Treatment of Irritable Bowel Syndrome 4Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 2Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 3Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8BLU MED Announces New Medical Preparedness Contracts 7283 1BLU MED Announces New Medical Preparedness Contracts 7283 2BioSpace Launches 2nd Edition of Southern Pharm 28TM 29 Hotbed Campaign 2027 1BioSpace Launches 2nd Edition of Southern Pharm 28TM 29 Hotbed Campaign 2027 2U S Patent 7 299 083 Awarded to Signalife 2023 1U S Patent 7 299 083 Awarded to Signalife 2023 2FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 1FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 2FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 3FDA Approves Cymbalta 28R 29 for Maintenance Treatment of Major Depressive Disorder 953 4
...uture Pandemics , ,BETHESDA, Md., April 2, 2007--O...anish influenza pandemic is why it struck differen...cipalities such as,St. Louis spared the fate of th...emented similar public health measures? What made ...es funded by the,National Institutes of Health (NI...
...ent Therapy Significantly,Improved Absorption of F...y and DAYTON, Ohio, April 04, 2007 /PRNewswire/ --..., today unveiled,data from two phase III clinical ... formerly EUR-1008, for the treatment of,Exocrine ...ug,Administration (FDA) granted fast track status ...
Other Medicine Technology:Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5
Chemstrip Micral test strips are an optically read immunoassay to detect albumin in urine samples. When the test strip is dipped into a urine sample, urine passes via a wick fleece into the conjugate
The DOT-approved A150 test is used for workplace testing, most publicly for federally mandated testing of transportation workers, but also in private company "drug free workplace" programs. Each hash
...e available in 14 configurations including the new...genics Antibody Technology, the SureStep™ MD...assay targeted to detect MDMA that has an affinity...any isomer of methamphetamine or amphetamine.The S...
The InstaCheck® multi-drug test device provides clear, reliable results simply and easily. Negative results can be determined in as few as 3 minutes; positive results require only 8 minutes. A si
Medicine Products: